BRENNEN

Industries / Health / Healthcare / Medical spas

Complications

This work is about what goes wrong after a cosmetic treatment, how it is put right, and how harm is found and counted.

7

Milestones achieved, from 2004 to 2025.

2

To watch for: announced, not yet confirmed outside.

2

Open deliverables. Nobody has shipped them.

The road

AchievedWatch forOpen

Achieved

  1. 2004

    Botulism from unlicensed toxin

    On 27 November 2004 four people with suspected botulism, a paralysing illness caused by botulinum toxin, were reported to the US Centers for Disease Control and Prevention (CDC) after cosmetic injections. All four had been injected with a highly concentrated toxin that was not licensed for use in people; investigators estimated that they may have received 2,857 times the estimated lethal dose, and found toxin in the blood of three. The authors wrote that no botulism with toxin detectable in the blood had been tied to cosmetic or medical toxin injections before.

    LessonThe authors concluded that unlicensed toxin can cause life-threatening illness and called for rules on its marketing, sale and use.

    ebi.ac.uk

    Credit

    CDC investigators, D. S. Chertow and colleagues

  2. 2013

    Laser lawsuits counted

    A laser for hair removal works by heating the hair root and can burn and scar the skin around it. Searching a national database of public US legal documents, H. R. Jalian, C. A. Jalian and M. M. Avram found 174 laser injury cases from 1985 to 2012, with hair removal the most litigated. In their second study, the share of cases involving an operator who was not a doctor rose from 36.3% in 2008 to 77.8% in 2011, and 64% of those operators worked outside a traditional medical setting. A 2022 update found 69 cases from 2012 to 2020, 71% involving such an operator.

    ebi.ac.ukebi.ac.ukebi.ac.uk

    Credit

    H. R. Jalian, C. A. Jalian and M. M. Avram

  3. 2015

    Blindness cases counted

    Filler injected into the face can enter an artery and block the blood supply to the eye. K. Beleznay and colleagues gathered every published case of vision changes after filler: 98 in a 2015 review, with the glabella, between the eyebrows, the riskiest site (38.8%) and the patient's own fat the most common filler (47.9%). Updates found 48 more cases to September 2018 and 365 more from September 2018 to March 2023, by then mostly hyaluronic acid filler (79.6%) and most often in the nose (40.6%). Of the later cases with a recorded outcome, 68.2% had no recovery of vision.

    LessonThe 2015 review found no treatment that consistently restored sight.

    ebi.ac.ukebi.ac.ukebi.ac.uk

    Credit

    K. Beleznay, J. D. A. Carruthers, S. Humphrey, D. Jones and colleagues

  4. 2017

    Dissolving the blockage

    Hyaluronic acid filler can be broken down by hyaluronidase, an enzyme. C. DeLorenzi published a protocol of repeated high doses injected hourly into the starved skin until blood flow returns, and reported no partial or complete skin loss in two years of use when treatment began within two days. A 2026 review by P. Kamrani, S. E. Cox, K. Beleznay and S. Humphrey names prompt high-dose hyaluronidase as central to treating a blocked vessel.

    LessonIt works far less well for the eye: a 2026 review of 22 cases of vision loss after nose filler found full recovery in 27%, with loss often permanent despite hyaluronidase.

    ebi.ac.ukebi.ac.ukebi.ac.uk

    Credit

    C. DeLorenzi

  5. 2021

    Fat-melting injections spread infection

    Mesotherapy is a series of small injections of drugs or vitamins meant to dissolve fat. In 2021 an infectious disease doctor in Montréal reported to public health a patient with spreading inflamed lumps under the skin after mesotherapy. Investigators found four people infected with Mycobacterium abscessus, a bacterium that resists many antibiotics, all treated by the same esthetician within one month, and genome sequencing showed their bacteria differed by no more than two single-letter DNA changes.

    LessonThese infections are not a reportable disease in Québec; the outbreak came to light because a doctor reported it anyway.

    pmc.ncbi.nlm.nih.gov

    Credit

    Montréal public health department; Xavier Quan-Nguyen and colleagues

  6. 2024

    HIV traced to spa facials

    A "vampire facial" pricks the face with fine needles (microneedling) and applies platelet-rich plasma made from the client's own blood. From 2018 the New Mexico Department of Health and CDC investigated a spa that offered it and found four former clients, and the sexual partner of one, diagnosed with HIV during 2018 to 2023, with closely matching virus strains. CDC wrote in 2024 that HIV spread through cosmetic injection services had not been documented before. The spa was unlicensed, did not follow infection control and kept no client records, so investigators had to rebuild the client list from other records.

    LessonThe authors call for infection control and client records to be required at spas that offer injections.

    pmc.ncbi.nlm.nih.gov

    Credit

    New Mexico Department of Health and CDC, Stadelman-Behar and colleagues

  7. 2025

    Botulism cluster in England

    Between 4 June and 6 August 2025 the UK Health Security Agency confirmed 41 cases of iatrogenic botulism, botulism caused by a treatment, after cosmetic toxin injections in five English regions; some patients needed help to breathe, and evidence pointed to an unlicensed product. The medicines regulator, the MHRA, said treatments had been given in bedrooms, kitchens, hair salons and by mobile services, and that it had seized more than 4,700 vials of unlicensed toxin since May 2023, almost all made in South Korea. In July 2026 the MHRA had the product information of every type A toxin updated to warn of iatrogenic botulism, whose symptoms can take up to four weeks to appear.

    gov.ukgov.ukgov.uk

    Credit

    UK Health Security Agency; MHRA

Watch for

  1. Scanning before injecting

    A handheld ultrasound probe lets an injector see arteries under the skin before and during an injection. A May 2026 review states that ultrasound-guided injections "improve precision, prevent complications"; the comparisons it cites are small, such as a study that found less bruising and vessel trauma than with blind injections.

    Achieved whena study large enough to count blocked vessels, which a 2026 review puts at fewer than 0.01% of injection sites, finds fewer of them with ultrasound than without, run by a group not funded by an ultrasound maker.

    pmc.ncbi.nlm.nih.govebi.ac.uk

    Claimed by

    Arrigoni and colleagues, Journal of Ultrasound, May 2026

  2. Prosecutions after the cluster

    The MHRA said in August 2025 that its Criminal Enforcement Unit had opened "a number of criminal investigations" after the botulism cases, and that anyone who sells or supplies unlicensed toxin faces up to two years in prison.

    Achieved whena court convicts a supplier linked to the 2025 cases.

    gov.uk

    Claimed by

    MHRA, August 2025

Open

  1. 01

    Blindness cases, kept current

    An open register, one row per patient, of every published case of vision loss after a cosmetic filler, from the earliest to this month. Each row gives the injection site, the product, who injected and where when the paper says, the treatment and how soon it began, and the visual outcome, linked to its paper. A script finds new case reports each month.

    The brief
    Credit · unclaimed
  2. 02

    Where the harm happened

    A labelled set of US FDA adverse event reports on dermal fillers, and an open tool that reads each report's free text and records the setting (med spa, doctor's office, salon, home) and who injected, whenever the report says so. Publish, by year, how many reports name a setting at all, the counts by setting where they do, and a one-page proposal for a "setting" field on the FDA's reporting form.

    The brief
    Credit · unclaimed

Open 01 · the brief

Blindness cases, kept current

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

An open register, one row per patient, of every published case of vision loss after a cosmetic filler, from the earliest to this month. Each row gives the injection site, the product, who injected and where when the paper says, the treatment and how soon it began, and the visual outcome, linked to its paper. A script finds new case reports each month.

Why it is still open

The counts are snapshots published years apart: 98 cases in 2015, 48 more to September 2018, and 365 more to March 2023. Cases since then appear in narrower 2026 reviews that use different rules, such as 22 cases after nose filler. A search of Europe PMC found no public, case-level register that is kept up to date.

ebi.ac.ukebi.ac.uk

Built with what exists

The Europe PMC and NCBI E-utilities interfaces to find case reports; an AI model to draft each row from the paper, such as Meta's Muse Ember (Notes: "The jobs agents repeat"); two people checking every row; a Git repository and Datasette.

  1. First step

    Run the 2024 review's search terms in Europe PMC for April 2023 onward and count the candidate case reports.

  2. Done looks like

    Every case from April 2023 onward plus as many earlier cases as the published papers allow, each checked by two people who agree on at least 95% of fields; outcome shares by site and product that match the 2024 review within 2 percentage points for the period both cover; six monthly updates in a row.

Open 02 · the brief

Where the harm happened

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

A labelled set of US FDA adverse event reports on dermal fillers, and an open tool that reads each report's free text and records the setting (med spa, doctor's office, salon, home) and who injected, whenever the report says so. Publish, by year, how many reports name a setting at all, the counts by setting where they do, and a one-page proposal for a "setting" field on the FDA's reporting form.

Why it is still open

Nobody knows where complications happen. The FDA's MAUDE database, the record of medical device problem reports, holds 23,202 reports for "Implant, Dermal, For Aesthetic Use", the code for fillers, and only 47 of their narratives mention a med spa or medical spa (this session's count through the openFDA interface, 19 November 2026). A voluntary registry run with the American Society for Dermatologic Surgery Association received 199 reports from March 2021 to August 2025, and its authors say it cannot estimate how often harm occurs. Texas's 2025 bill analysis cited a survey in which most dermatologic surgeons said 61% to 100% of the complications they saw came from med spas, which is their estimate, not a count.

api.fda.govpmc.ncbi.nlm.nih.govcapitol.texas.gov

Built with what exists

The openFDA device event interface; an AI model to tag each narrative, such as Meta's Muse Ember (Notes: "The jobs agents repeat"), checked against reports labelled by hand; Python and DuckDB.

  1. First step

    Download the 2025 filler reports from openFDA and label 200 narratives by hand for setting and injector.

  2. Done looks like

    All 23,202 filler reports tagged; 400 reports labelled by two people, with the tool agreeing with them on at least 95%; a public yearly table of the share of reports that state a setting and an injector type; the code and labels published.